| Literature DB >> 31552694 |
Sorina Chiorean1, Isaac Antwi1, Daniel W Carney2, Ioli Kotsogianni3, Andrew M Giltrap4, Francesca M Alexander5, Stephen A Cochrane5, Richard J Payne4, Nathaniel I Martin3, Antoine Henninot2, John C Vederas1.
Abstract
The prevalence of life-threatening, drug-resistant microbial infections has challenged researchers to consider alternatives to currently available antibiotics. Teixobactin is a recently discovered "resistance-proof" antimicrobial peptide that targets the bacterial cell wall precursor lipid II. In doing so, teixobactin exhibits potent antimicrobial activity against a wide range of Gram-positive organisms. Herein we demonstrate that teixobactin and several structural analogues are capable of binding lipid II from both Gram-positive and Gram-negative bacteria. Furthermore, we show that when combined with known outer membrane-disrupting peptides, teixobactin is active against Gram-negative organisms.Entities:
Keywords: antibiotics; antimicrobial resistance; macrocyclic peptides; medicinal chemistry; peptides
Mesh:
Substances:
Year: 2019 PMID: 31552694 DOI: 10.1002/cbic.201900504
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164